Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

4.320 -0.200 (-4.42%)
Streaming Delayed Price Updated: 2:45 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 336,863
Open 4.520
Bid (Size) 4.310 (8)
Ask (Size) 4.330 (8)
Prev. Close 4.520
Today's Range 4.280 - 4.585
52wk Range 3.950 - 22.64
Shares Outstanding 35,817,154
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings. 
Via Benzinga

Performance

YTD
-79.19%
-79.19%
1 Month
-19.70%
-19.70%
3 Month
-24.48%
-24.48%
6 Month
-58.94%
-58.94%
1 Year
-73.94%
-73.94%

More News

Read More
Peeling Back The Layers: Exploring Nevro Through Analyst Insights
Via Benzinga
Earnings Scheduled For November 11, 2024
Via Benzinga
A Look Ahead: Nevro's Earnings Forecast
Via Benzinga
Breaking Down Nevro: 10 Analysts Share Their Views
Via Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
Evaluating Nevro: Insights From 8 Financial Analysts
Via Benzinga
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Via Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
NVRO Stock Earnings: Nevro Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
Via AB Newswire
Where Nevro Stands With Analysts
Via Benzinga
Why Nevro Stock Lagged the Market on Thursday
Via The Motley Fool
Analyst Scoreboard: 4 Ratings For Nevro
Via Benzinga
Nevro: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Via Benzinga
What Analysts Are Saying About Nevro Stock
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Nevro
Via Benzinga
Where Nevro Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Nevro
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.